Review of 103 S wedish H ealthcare Q uality R egistries L Emilsson, B Lindahl, M Köster, M Lambe, JF Ludvigsson Journal of internal medicine 277 (1), 94-136, 2015 | 425 | 2015 |
Effect of colonoscopy screening on risks of colorectal cancer and related death M Bretthauer, M Løberg, P Wieszczy, M Kalager, L Emilsson, K Garborg, ... New England Journal of Medicine 387 (17), 1547-1556, 2022 | 311 | 2022 |
Epidemiology and risk factors of colorectal polyps M Øines, LM Helsingen, M Bretthauer, L Emilsson Best Practice & Research Clinical Gastroenterology 31 (4), 419-424, 2017 | 169 | 2017 |
Examining bias in studies of statin treatment and survival in patients with cancer L Emilsson, X García-Albéniz, RW Logan, EC Caniglia, M Kalager, ... JAMA oncology 4 (1), 63-70, 2018 | 167 | 2018 |
The COVID-19 pandemic in Norway and Sweden–threats, trust, and impact on daily life: a comparative survey LM Helsingen, E Refsum, DK Gjøstein, M Løberg, M Bretthauer, ... BMC public health 20, 1-10, 2020 | 141 | 2020 |
Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis HC Jodal, LM Helsingen, JC Anderson, L Lytvyn, PO Vandvik, L Emilsson BMJ open 9 (10), e032773, 2019 | 110 | 2019 |
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study M Song, L Emilsson, SR Bozorg, LH Nguyen, AD Joshi, K Staller, J Nayor, ... The Lancet Gastroenterology & Hepatology 5 (6), 537-547, 2020 | 100 | 2020 |
Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study L Emilsson, JG Smith, J West, O Melander, JF Ludvigsson European heart journal 32 (19), 2430-2437, 2011 | 98 | 2011 |
Rationale and design of the European Polyp Surveillance (EPoS) trials R Jover, M Bretthauer, E Dekker, Ø Holme, MF Kaminski, M Løberg, ... Endoscopy, 571-578, 2016 | 97 | 2016 |
The continuing uncertainty about cancer risk in inflammatory bowel disease HO Adami, M Bretthauer, L Emilsson, MA Hernán, M Kalager, ... Gut 65 (6), 889-893, 2016 | 69 | 2016 |
Guidance for health care leaders during the recovery stage of the COVID-19 pandemic: a consensus statement JM Geerts, D Kinnair, P Taheri, A Abraham, J Ahn, R Atun, L Barberia, ... JAMA network open 4 (7), e2120295-e2120295, 2021 | 61 | 2021 |
Perinatal risk factors for development of celiac disease in children, based on the prospective Norwegian Mother and Child Cohort Study L Emilsson, MC Magnus, K Størdal Clinical Gastroenterology and Hepatology 13 (5), 921-927, 2015 | 61 | 2015 |
The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease L Emilsson, R Carlsson, M Holmqvist, S James, JF Ludvigsson Alimentary pharmacology & therapeutics 37 (9), 905-914, 2013 | 60 | 2013 |
Cardiovascular disease in patients with coeliac disease: a systematic review and meta-analysis L Emilsson, B Lebwohl, J Sundström, JF Ludvigsson Digestive and Liver Disease 47 (10), 847-852, 2015 | 53 | 2015 |
Psychiatric disorders in patients with a diagnosis of celiac disease during childhood from 1973 to 2016 B Lebwohl, L Haggård, L Emilsson, J Söderling, B Roelstraete, ... Clinical Gastroenterology and Hepatology 19 (10), 2093-2101. e13, 2021 | 49 | 2021 |
Autoimmune disease in first-degree relatives and spouses of individuals with celiac disease L Emilsson, C Wijmenga, JA Murray, JF Ludvigsson Clinical Gastroenterology and Hepatology 13 (7), 1271-1277. e2, 2015 | 49 | 2015 |
Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease L Emilsson, B Andersson, P Elfström, PHR Green, JF Ludvigsson Journal of the American Heart Association 1 (3), e001594, 2012 | 49 | 2012 |
Anxiety after coeliac disease diagnosis predicts mucosal healing: a population‐based study JF Ludvigsson, B Lebwohl, Q Chen, G Bröms, RL Wolf, PHR Green, ... Alimentary pharmacology & therapeutics 48 (10), 1091-1098, 2018 | 48 | 2018 |
Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease L Emilsson, C Semrad, B Lebwohl, PHR Green, JF Ludvigsson Gastroenterology 159 (5), 1686-1694. e2, 2020 | 45 | 2020 |
Inflammatory bowel disease is more common in patients with IgA nephropathy and predicts progression of ESKD: a Swedish population-based cohort study J Rehnberg, A Symreng, JF Ludvigsson, L Emilsson Journal of the American Society of Nephrology 32 (2), 411-423, 2021 | 44 | 2021 |